Quinoline derivatives for the treatment of inflammatory diseases

Details for Australian Patent Application No. 2008228067 (hide)

Owner AstraZeneca AB

Inventors Ebden, Mark; Guile, Simon David

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008228067

PCT Pub. Number WO2008/114002

Priority 60/896,298 22.03.07 US

Filing date 19 March 2008

Wipo publication date 25 September 2008

Acceptance publication date 8 December 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

8 October 2009 PCT application entered the National Phase

  PCT publication WO2008/114002 Priority application(s): WO2008/114002

8 December 2011 Application Accepted

  Published as AU-B-2008228067

5 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008228078-Coating of confectionery and tablets

2008228065-Methods of producing haploid and doubled haploid oil palms